Searched for
SUSHIL SURI
Morepen to hire 1,000 medical representatives to strengthen formulations bizMorepen Laboratories plans to significantly expand its medical representative team, adding over 1,000 members in the next three years, with...- Morepen Laboratories Q3 Results: Profit dips 10% to Rs 22 crNet revenue, however, rose to Rs 399.19 crore in the third quarter as compared with Rs 310.26 crore in the same period of 2020-21, Morepen ...
- Morepen gets USFDA nod to market generic anti-allergy drugDrug firm Morepen Laboratories on Friday said it has received approval from the US health regulator to market its anti-allergy drug Fexofin...
- Morepen Labs Q2 results: Net profit up 38% at Rs 37 crore"With massive increase in active pharmaceutical ingredient (API) demand globally and more particularly with frequent supply disruptions fro...
- Morepen shareholders approve new unit to house medical device bizThe company shareholders have given their approval for the creation of the new unit on September 28 during the course of the 36th annual ge...
- Morepen gets shareholder nod to raise Rs 433 croreMorepen said it plans to utilise the raised capital to expand research and development (R&D) facilities and to set up a new USFDA standard ...
- Morepen Labs betting big on diagnostics devices segment: CMDThe company is also planning an expansion of its pharmaceutical complex at Baddi in Himachal Pradesh and is looking at an investment of ove...
- Morepen Labs Q2 results: Net profit jumps over 6-fold to Rs 27crTotal revenue stood at Rs 340.12 crore for the quarter under consideration. It was Rs 216.24 crore for the same period a year ago, it added.
- Morepen Labs Q1 results: Net profit jumps over two-fold to Rs 19.36 croreThe company had posted a net profit of Rs 7.65 crore in the corresponding period of previous fiscal, Morepen Laboratories said in a filing ...
- Morepen Labs Q4 results: Net profit rises 5% to Rs 11 croreIts consolidated total revenue stood at Rs 208.38 crore for the quarter under consideration.
- Morepen inks pact with Vésale Pharma to boost presence in Rs 1000-crore probiotics marketMorepen, which currently does not have a presence in the probiotic market for gastroenterology, hopes to use its latest agreement to captur...
- Exports major contributor to API revenues: Sushil Suri, Morepen LabsThe second growth which is coming from in the domestic market is from home diagnostics.
- Morepen to sell anti-asthmatic drug Montelukast in Europe, North AmericaPharma firm Morepen Laboratories today said it is preparing to sell anti-asthmatic drug Montelukast in European and North American markets.
- Morepen lines up debt recastMorepen Laboratories, the loss-making, debt-laden pharma company, has struck a deal with lenders to restructure its debt and is also prepar...
- Avenue Capital to pick 15% in Morepen for Rs 80 croreUS-based Avenue Capital, a hedge fund that focuses on distressed and undervalued debt and equity opportunities, is in an advanced stage of ...
- Morepen Lab partly settles debt from banksPharmaceutical company Morepen Laboratories on Tuesday said it has issued fresh capital of Rs 103 crore to banks and financial institutions...
- StanChart set to buy Morepen stakeAn investment arm of Standard Chartered Bank is close to acquiring stake in the ailing Morepen Labs, after private equity fund Avenue Asia ...
- PE investors to buy 40% in Morepen LabsRana Talwar’s Sabre Capital, Spinnaker Capital and Deutsche Bank are together acquiring about 40% stake in Morepen Laboratories.
- Private equity funds in talks to buy stake in Morepen LabsA couple of private equity funds such as Clearwater Capital and Spinnaker Capital are understood to be in the lead to pick up a significant...
- 3 more ITDC hotels sold, HCI divestment takes offNEW DELHI: THE GOVERNMENT has approved the sale of three India Tourism Development Corporation hotels and Centaur Hotel, Mumbai.
Load More
